LAG-3 Expression Predicts Outcome in Stage II Colon CancerGaëlle Rhyner Agocs, Martin D. Berger|Journal of Personalized Medicine|2021Cited by 55
Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 yearsAlexander D. Heini, Thomas Pabst, Martin D. Berger et al.|Leukemia Research|2016Cited by 27
Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS -mutated rectal cancer: A phase I/II trial (SAKK 41/08)Roger von Moos, Kathrin Zaugg, Dieter Koeberle et al.|European Journal of Cancer|2017Cited by 27
Zevalin and BEAM (Z‐BEAM) versus rituximab and BEAM (R‐BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphomaMartin D. Berger, Thomas Pabst, Yara Banz et al.|Hematological Oncology|2015Cited by 17
Neoadjuvant radiotherapy (RT) combined with capecitabine (Cape) and sorafenib (Sor) in patients (pts) with locally advanced, k-ras-mutated rectal cancer (LARC): A phase I/II trial SAKK 41/08.Roger von Moos, Kathrin Zaugg, Dieter Koeberle et al.|Journal of Clinical Oncology|2014Cited by 5